▶ 調査レポート

世界の原発性アルドステロン症市場：市場規模・現状・予測
• 英文タイトル：Global Primary Aldosteronism Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界の原発性アルドステロン症市場：市場規模・現状・予測 / Global Primary Aldosteronism Market Size, Status and Forecast 2019-2025 / QYR9N7880資料のイメージです。• レポートコード：QYR9N7880
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、99ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ
• 販売価格（消費税別）
  Single User￥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License￥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当資料は、原発性アルドステロン症のグローバル市場について調査・分析したレポートで、種類別（タイプI、タイプII）、用途別（病院と診療所、研究機関、学術機関）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・原発性アルドステロン症の世界市場規模
・主要企業別市場シェア
・原発性アルドステロン症の世界市場規模：種類別（タイプI、タイプII）
・原発性アルドステロン症の世界市場規模：用途別（病院と診療所、研究機関、学術機関）
・原発性アルドステロン症のアメリカ市場規模（種類別、用途別）
・原発性アルドステロン症のヨーロッパ市場規模（種類別、用途別）
・原発性アルドステロン症の中国市場規模（種類別、用途別）
・原発性アルドステロン症の日本市場規模（種類別、用途別）
・原発性アルドステロン症の東南アジア市場規模（種類別、用途別）
・原発性アルドステロン症のインド市場規模（種類別、用途別）
・原発性アルドステロン症の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・原発性アルドステロン症の世界市場予測（2019年-2025年）
・原発性アルドステロン症の地域別市場予測（2019年-2025年）
...

Primary aldosteronism refers to the excess production of the hormone aldosterone from the adrenal glands, resulting in low renin levels. This abnormality is caused by hyperplasia or tumors. Many suffer from fatigue, potassium deficiency and high blood pressure which may cause poor vision, confusion or headaches.The treatment for hyperaldosteronism depends on the underlying cause. In people with a single benign tumor (adenoma), surgical removal (adrenalectomy) may be curative. This is usually performed laparoscopically, through several very small incisions. For people with hyperplasia of both glands, successful treatment is often achieved with spironolactone or eplerenone, drugs that block the effect of aldosterone.
In 2018, the global Primary Aldosteronism market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Primary Aldosteronism status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Primary Aldosteronism development in United States, Europe and China.

The key players covered in this study
Pfizer
Sun Pharmaceutical Industries
Bristol Laboratories
CMP Pharma
Koninklijke Philips
GE Healthcare
Siemens
Shimadzu Corporation
Canon

Market segment by Type, the product can be split into
Type I
Type II

Market segment by Application, split into
Hospitals & Clinics
Research Organization
Academic Institutes

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Primary Aldosteronism status, future forecast, growth opportunity, key market and key players.
To present the Primary Aldosteronism development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Primary Aldosteronism are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Primary Aldosteronism Market Size Growth Rate by Type (2014-2025)
1.4.2 Type I
1.4.3 Type II
1.5 Market by Application
1.5.1 Global Primary Aldosteronism Market Share by Application (2014-2025)
1.5.2 Hospitals & Clinics
1.5.3 Research Organization
1.5.4 Academic Institutes
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Primary Aldosteronism Market Size
2.2 Primary Aldosteronism Growth Trends by Regions
2.2.1 Primary Aldosteronism Market Size by Regions (2014-2025)
2.2.2 Primary Aldosteronism Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Primary Aldosteronism Market Size by Manufacturers
3.1.1 Global Primary Aldosteronism Revenue by Manufacturers (2014-2019)
3.1.2 Global Primary Aldosteronism Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Primary Aldosteronism Market Concentration Ratio (CR5 and HHI)
3.2 Primary Aldosteronism Key Players Head office and Area Served
3.3 Key Players Primary Aldosteronism Product/Solution/Service
3.4 Date of Enter into Primary Aldosteronism Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Primary Aldosteronism Market Size by Type (2014-2019)
4.2 Global Primary Aldosteronism Market Size by Application (2014-2019)

5 United States
5.1 United States Primary Aldosteronism Market Size (2014-2019)
5.2 Primary Aldosteronism Key Players in United States
5.3 United States Primary Aldosteronism Market Size by Type
5.4 United States Primary Aldosteronism Market Size by Application

6 Europe
6.1 Europe Primary Aldosteronism Market Size (2014-2019)
6.2 Primary Aldosteronism Key Players in Europe
6.3 Europe Primary Aldosteronism Market Size by Type
6.4 Europe Primary Aldosteronism Market Size by Application

7 China
7.1 China Primary Aldosteronism Market Size (2014-2019)
7.2 Primary Aldosteronism Key Players in China
7.3 China Primary Aldosteronism Market Size by Type
7.4 China Primary Aldosteronism Market Size by Application

8 Japan
8.1 Japan Primary Aldosteronism Market Size (2014-2019)
8.2 Primary Aldosteronism Key Players in Japan
8.3 Japan Primary Aldosteronism Market Size by Type
8.4 Japan Primary Aldosteronism Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Primary Aldosteronism Market Size (2014-2019)
9.2 Primary Aldosteronism Key Players in Southeast Asia
9.3 Southeast Asia Primary Aldosteronism Market Size by Type
9.4 Southeast Asia Primary Aldosteronism Market Size by Application

10 India
10.1 India Primary Aldosteronism Market Size (2014-2019)
10.2 Primary Aldosteronism Key Players in India
10.3 India Primary Aldosteronism Market Size by Type
10.4 India Primary Aldosteronism Market Size by Application

11 Central & South America
11.1 Central & South America Primary Aldosteronism Market Size (2014-2019)
11.2 Primary Aldosteronism Key Players in Central & South America
11.3 Central & South America Primary Aldosteronism Market Size by Type
11.4 Central & South America Primary Aldosteronism Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Primary Aldosteronism Introduction
12.1.4 Pfizer Revenue in Primary Aldosteronism Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Sun Pharmaceutical Industries
12.2.1 Sun Pharmaceutical Industries Company Details
12.2.2 Company Description and Business Overview
12.2.3 Primary Aldosteronism Introduction
12.2.4 Sun Pharmaceutical Industries Revenue in Primary Aldosteronism Business (2014-2019)
12.2.5 Sun Pharmaceutical Industries Recent Development
12.3 Bristol Laboratories
12.3.1 Bristol Laboratories Company Details
12.3.2 Company Description and Business Overview
12.3.3 Primary Aldosteronism Introduction
12.3.4 Bristol Laboratories Revenue in Primary Aldosteronism Business (2014-2019)
12.3.5 Bristol Laboratories Recent Development
12.4 CMP Pharma
12.4.1 CMP Pharma Company Details
12.4.2 Company Description and Business Overview
12.4.3 Primary Aldosteronism Introduction
12.4.4 CMP Pharma Revenue in Primary Aldosteronism Business (2014-2019)
12.4.5 CMP Pharma Recent Development
12.5 Koninklijke Philips
12.5.1 Koninklijke Philips Company Details
12.5.2 Company Description and Business Overview
12.5.3 Primary Aldosteronism Introduction
12.5.4 Koninklijke Philips Revenue in Primary Aldosteronism Business (2014-2019)
12.5.5 Koninklijke Philips Recent Development
12.6 GE Healthcare
12.6.1 GE Healthcare Company Details
12.6.2 Company Description and Business Overview
12.6.3 Primary Aldosteronism Introduction
12.6.4 GE Healthcare Revenue in Primary Aldosteronism Business (2014-2019)
12.6.5 GE Healthcare Recent Development
12.7 Siemens
12.7.1 Siemens Company Details
12.7.2 Company Description and Business Overview
12.7.3 Primary Aldosteronism Introduction
12.7.4 Siemens Revenue in Primary Aldosteronism Business (2014-2019)
12.7.5 Siemens Recent Development
12.8 Shimadzu Corporation
12.8.1 Shimadzu Corporation Company Details
12.8.2 Company Description and Business Overview
12.8.3 Primary Aldosteronism Introduction
12.8.4 Shimadzu Corporation Revenue in Primary Aldosteronism Business (2014-2019)
12.8.5 Shimadzu Corporation Recent Development
12.9 Canon
12.9.1 Canon Company Details
12.9.2 Company Description and Business Overview
12.9.3 Primary Aldosteronism Introduction
12.9.4 Canon Revenue in Primary Aldosteronism Business (2014-2019)
12.9.5 Canon Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Primary Aldosteronism Key Market Segments
Table Key Players Primary Aldosteronism Covered
Table Global Primary Aldosteronism Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Primary Aldosteronism Market Size Market Share by Type 2014-2025
Figure Type I Figures
Table Key Players of Type I
Figure Type II Figures
Table Key Players of Type II
Table Global Primary Aldosteronism Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals & Clinics Case Studies
Figure Research Organization Case Studies
Figure Academic Institutes Case Studies
Figure Primary Aldosteronism Report Years Considered
Table Global Primary Aldosteronism Market Size 2014-2025 (Million US$)
Figure Global Primary Aldosteronism Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Primary Aldosteronism Market Size by Regions 2014-2025 (Million US$)
Table Global Primary Aldosteronism Market Size by Regions 2014-2019 (Million US$)
Table Global Primary Aldosteronism Market Share by Regions 2014-2019
Figure Global Primary Aldosteronism Market Share by Regions 2014-2019
Figure Global Primary Aldosteronism Market Share by Regions 2019
Table Market Top Trends
Table Global Primary Aldosteronism Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Primary Aldosteronism Market Share by Manufacturers (2014-2019)
Figure Global Primary Aldosteronism Market Share by Manufacturers in 2018
Table Global Primary Aldosteronism Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Primary Aldosteronism Product/Solution/Service
Table Date of Enter into Primary Aldosteronism Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Primary Aldosteronism Market Size by Type (2014-2019) (Million US$)
Table Global Primary Aldosteronism Market Size Share by Type (2014-2019)
Figure Global Primary Aldosteronism Market Size Market Share by Type (2014-2019)
Table Global Primary Aldosteronism Market Size by Application (2014-2019) (Million US$)
Table Global Primary Aldosteronism Market Size Share by Application (2014-2019)
Figure Global Primary Aldosteronism Market Size Market Share by Application (2014-2019)
Figure Global Primary Aldosteronism Revenue Market Share by Application in 2018
Figure United States Primary Aldosteronism Market Size 2014-2019 (Million US$)
Table United States Key Players Primary Aldosteronism Revenue (2018-2019) (Million US$)
Table United States Key Players Primary Aldosteronism Market Share (2018-2019)
Table United States Primary Aldosteronism Market Size by Type (2014-2019) (Million US$)
Table United States Primary Aldosteronism Market Share by Type (2014-2019)
Table United States Primary Aldosteronism Market Size by Application (2014-2019) (Million US$)
Table United States Primary Aldosteronism Market Share by Application (2014-2019)
Figure Europe Primary Aldosteronism Market Size 2014-2019 (Million US$)
Table Europe Key Players Primary Aldosteronism Revenue (2018-2019) (Million US$)
Table Europe Key Players Primary Aldosteronism Market Share (2018-2019)
Table Europe Primary Aldosteronism Market Size by Type (2014-2019) (Million US$)
Table Europe Primary Aldosteronism Market Share by Type (2014-2019)
Table Europe Primary Aldosteronism Market Size by Application (2014-2019) (Million US$)
Table Europe Primary Aldosteronism Market Share by Application (2014-2019)
Figure China Primary Aldosteronism Market Size 2014-2019 (Million US$)
Table China Key Players Primary Aldosteronism Revenue (2018-2019) (Million US$)
Table China Key Players Primary Aldosteronism Market Share (2018-2019)
Table China Primary Aldosteronism Market Size by Type (2014-20189) (Million US$)
Table China Primary Aldosteronism Market Share by Type (2014-2019)
Table China Primary Aldosteronism Market Size by Application (2014-2019) (Million US$)
Table China Primary Aldosteronism Market Share by Application (2014-2019)
Figure Japan Primary Aldosteronism Market Size 2014-2019 (Million US$)
Table Japan Key Players Primary Aldosteronism Revenue (2018-2019) (Million US$)
Table Japan Key Players Primary Aldosteronism Market Share (2018-2019)
Table Japan Primary Aldosteronism Market Size by Type (2014-2019) (Million US$)
Table Japan Primary Aldosteronism Market Share by Type (2014-2019)
Table Japan Primary Aldosteronism Market Size by Application (2014-2019) (Million US$)
Table Japan Primary Aldosteronism Market Share by Application (2014-2019)
Figure Southeast Asia Primary Aldosteronism Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Primary Aldosteronism Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Primary Aldosteronism Market Share (2018-2019)
Table Southeast Asia Primary Aldosteronism Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Primary Aldosteronism Market Share by Type (2014-2019)
Table Southeast Asia Primary Aldosteronism Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Primary Aldosteronism Market Share by Application (2014-2019)
Figure India Primary Aldosteronism Market Size 2014-2019 (Million US$)
Table India Key Players Primary Aldosteronism Revenue (2018-2019) (Million US$)
Table India Key Players Primary Aldosteronism Market Share (2018-2019)
Table India Primary Aldosteronism Market Size by Type (2014-2019) (Million US$)
Table India Primary Aldosteronism Market Share by Type (2014-2019)
Table India Primary Aldosteronism Market Size by Application (2014-2019) (Million US$)
Table India Primary Aldosteronism Market Share by Application (2014-2019)
Figure Central & South America Primary Aldosteronism Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Primary Aldosteronism Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Primary Aldosteronism Market Share (2018-2019)
Table Central & South America Primary Aldosteronism Market Size by Type (2014-2019) (Million US$)
Table Central & South America Primary Aldosteronism Market Share by Type (2014-2019)
Table Central & South America Primary Aldosteronism Market Size by Application (2014-2019) (Million US$)
Table Central & South America Primary Aldosteronism Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in Primary Aldosteronism Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in Primary Aldosteronism Business (2014-2019)
Table Pfizer Recent Development
Table Sun Pharmaceutical Industries Company Details
Table Sun Pharmaceutical Industries Revenue in Primary Aldosteronism Business (2014-2019)(Million US$)
Figure Sun Pharmaceutical Industries Revenue Growth Rate in Primary Aldosteronism Business (2014-2019)
Table Sun Pharmaceutical Industries Recent Development
Table Bristol Laboratories Company Details
Table Bristol Laboratories Revenue in Primary Aldosteronism Business (2014-2019)(Million US$)
Figure Bristol Laboratories Revenue Growth Rate in Primary Aldosteronism Business (2014-2019)
Table Bristol Laboratories Recent Development
Table CMP Pharma Company Details
Table CMP Pharma Revenue in Primary Aldosteronism Business (2014-2019)(Million US$)
Figure CMP Pharma Revenue Growth Rate in Primary Aldosteronism Business (2014-2019)
Table CMP Pharma Recent Development
Table Koninklijke Philips Company Details
Table Koninklijke Philips Revenue in Primary Aldosteronism Business (2014-2019)(Million US$)
Figure Koninklijke Philips Revenue Growth Rate in Primary Aldosteronism Business (2014-2019)
Table Koninklijke Philips Recent Development
Table GE Healthcare Company Details
Table GE Healthcare Revenue in Primary Aldosteronism Business (2014-2019)(Million US$)
Figure GE Healthcare Revenue Growth Rate in Primary Aldosteronism Business (2014-2019)
Table GE Healthcare Recent Development
Table Siemens Company Details
Table Siemens Revenue in Primary Aldosteronism Business (2014-2019)(Million US$)
Figure Siemens Revenue Growth Rate in Primary Aldosteronism Business (2014-2019)
Table Siemens Recent Development
Table Shimadzu Corporation Company Details
Table Shimadzu Corporation Revenue in Primary Aldosteronism Business (2014-2019)(Million US$)
Figure Shimadzu Corporation Revenue Growth Rate in Primary Aldosteronism Business (2014-2019)
Table Shimadzu Corporation Recent Development
Table Canon Company Details
Table Canon Revenue in Primary Aldosteronism Business (2014-2019)(Million US$)
Figure Canon Revenue Growth Rate in Primary Aldosteronism Business (2014-2019)
Table Canon Recent Development
Table Global Primary Aldosteronism Market Size by Regions (Million US$) 2019-2025
Figure Global Primary Aldosteronism Market Size Share by Regions (2019-2025)
Figure Global Primary Aldosteronism Market Size Share by Regions in 2025
Figure United States Primary Aldosteronism Market Size Forecast (2019-2025)(Million USD)
Figure Europe Primary Aldosteronism Market Size Forecast (2019-2025)(Million USD)
Figure China Primary Aldosteronism Market Size Forecast (2019-2025)(Million USD)
Figure Japan Primary Aldosteronism Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Primary Aldosteronism Market Size Forecast (2019-2025)(Million USD)
Figure India Primary Aldosteronism Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Primary Aldosteronism Market Size Forecast (2019-2025)(Million USD)
Table Global Primary Aldosteronism Market Size by Product (2019-2025) (Million US$)
Figure Global Primary Aldosteronism Market Size by Product (2019-2025)
Figure Global Primary Aldosteronism Market Size by Product in 2025
Table Global Primary Aldosteronism Market Size by Application (2019-2025) (Million US$)
Figure Global Primary Aldosteronism Market Size by Application (2019-2025)
Figure Global Primary Aldosteronism Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 世界の消費者グレードドローン市場：市場規模・現状・予測
    Global Consumer Grade Drone Market Size, Status and Forecast 2019-2025
    QYR9N7020 2019年6月14日 91Pages
    当資料は、消費者グレードドローンのグローバル市場について調査・分析したレポートで、種類別（クワッドローター、マルチローター）、用途別（空中、遊ぶ、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
    ...
  • 世界の軍用ドローン市場：市場規模・現状・予測
    Global Military Drone Market Size, Status and Forecast 2019-2025
    QYR9N7577 2019年6月14日 90Pages
    当資料は、軍用ドローンのグローバル市場について調査・分析したレポートで、種類別（固定翼、ヘリコプター、マルチローター）、用途別（偵察、デコイ、電子ジャミングインテグレータ、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含ま...
  • 世界のビットコイン取引市場：市場規模・現状・予測
    Global Litecoin Trading Market Size, Status and Forecast 2019-2025
    QYR9N7461 2019年6月14日 93Pages
    当資料は、ビットコイン取引のグローバル市場について調査・分析したレポートで、種類別（公開鍵ハッシュへの支払い、公開鍵への支払い、スクリプトハッシュへの支払い）、用途別（Eコマース、投資）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報など...
  • 世界のライトコイン交換市場：市場規模・現状・予測
    Global Litecoin Exchange Market Size, Status and Forecast 2019-2025
    QYR9N7460 2019年6月14日 95Pages
    当資料は、ライトコイン交換のグローバル市場について調査・分析したレポートで、種類別（公開鍵ハッシュへの支払い、公開鍵への支払い、スクリプトハッシュへの支払い）、用途別（Eコマース、投資）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報など...
  • 世界のIoTセキュリティ市場：市場規模・現状・予測
    Global IoT Security Market Size, Status and Forecast 2019-2025
    QYR9N7404 2019年6月14日 93Pages
    当資料は、IoTセキュリティのグローバル市場について調査・分析したレポートで、種類別（ネットワークセキュリティ、エンドポイントセキュリティ、クラウドセキュリティ、アプリケーションセキュリティ）、用途別（製造業、小売、健康管理、エネルギー管理、ビルディングおよびホームオートメーション、その他）、主要地...
  • 世界の5Gワイヤレステクノロジ市場：市場規模・現状・予測
    Global 5G Wireless Technology Market Size, Status and Forecast 2019-2025
    QYR9N8229 2019年6月14日 97Pages
    当資料は、5Gワイヤレステクノロジのグローバル市場について調査・分析したレポートで、種類別（タイプI、タイプII）、用途別（自動車、携帯電話、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界のデジタル財布市場：市場規模・現状・予測
    Global Digital Wallet Market Size, Status and Forecast 2019-2025
    QYR9N7108 2019年6月14日 98Pages
    当資料は、デジタル財布のグローバル市場について調査・分析したレポートで、種類別（オンライン財布、デスクトップ財布、おサイフケータイ）、用途別（BTC、ETC、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。<...
  • 世界のスマートモビリティ市場：市場規模・現状・予測
    Global Smart Mobility Market Size, Status and Forecast 2019-2025
    QYR9N8063 2019年6月14日 98Pages
    当資料は、スマートモビリティのグローバル市場について調査・分析したレポートで、種類別（コンサルティングサービス、統合サービス、メンテナンス）、用途別（交通管理、インフラ、モビリティインテリジェンス、顧客のモビリティ）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規...
  • 世界のA2Pメッセージング市場：市場規模・現状・予測
    Global A2P Messaging Market Size, Status and Forecast 2019-2025
    QYR9N8232 2019年6月14日 92Pages
    当資料は、A2Pメッセージングのグローバル市場について調査・分析したレポートで、種類別（グレイルートA2P SMS、OTT A2Pメッセージング、その他）、用途別（銀行業、発券業務、健康管理、コンテンツ支払い、オペレータの関与、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、イン...
  • 世界の自然言語処理市場：市場規模・現状・予測
    Global Natural Language Processing Market Size, Status and Forecast 2019-2025
    QYR9N7633 2019年6月14日 92Pages
    当資料は、自然言語処理のグローバル市場について調査・分析したレポートで、種類別（ルールベース、統計的、ハイブリッド）、用途別（ウェブ検索、言語翻訳、顧客サービス）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界の受託研究機関市場：市場規模・現状・予測世界の受託研究機関市場：市場規模・現状・予測 A contract research organization is a company that provides support to the pharmaceutical, biotechnology and medical device industries in the form of research services outsourced on a contract basis.A CRO may provide such services as biopharmaceutical development, biologic assay development, commerc…
  • 世界の生体内契約研究機関市場：市場規模・現状・予測世界の生体内契約研究機関市場：市場規模・現状・予測 In-vivo contract research organizations (CROs) are those institutions engaged in biopharmaceutical research on a contractual basis. With the growing popularity of biologics over small molecule drugs, the popularity of in-vivo CROs are gaining traction. With increasing demand for clinical scale manuf…
  • 世界の口腔がんの治療市場：市場規模・現状・予測世界の口腔がんの治療市場：市場規模・現状・予測 Oral cancer, also known as mouth cancer, is a type of head and neck cancer and is any cancerous tissue growth located in the oral cavity. It may arise as a primary lesion originating in any of the tissues in the mouth, by metastasis from a distant site of origin, or by extension from a neighboring a…
  • 世界の突然変異生成システム市場：市場規模・現状・予測世界の突然変異生成システム市場：市場規模・現状・予測 The mutation generation system is used for the functional analysis of the proteins. The mutation generation system enables the saturated libraries of transformed proteins in a response within a very less duration of time. The mutation generation system is a complete package of reagents for transposo…
  • 世界の心膜炎市場：市場規模・現状・予測世界の心膜炎市場：市場規模・現状・予測 Pericarditis is inflammation of the pericardium (the fibrous sac surrounding the heart). Symptoms typically include sudden onset of sharp chest pain. The pain may also be felt in the shoulders, neck, or back. It is typically better sitting up and worse with lying down or breathing deep. Other sympto…